Ofatumumab for B cell depletion in patients with systemic lupus erythematosus who are allergic to rituximab.

Masoud, Sherry; McAdoo, Stephen P; Bedi, Rachna; Cairns, Thomas D; Lightstone, Liz

Masoud, Sherry; McAdoo, Stephen P; Bedi, Rachna; Cairns, Thomas D; Lightstone, Liz.

Afiliación

Masoud S; Imperial College Lupus Centre, Imperial College Healthcare NHS Trust, Imperial College London, London, UK.
McAdoo SP; Imperial College Lupus Centre, Imperial College Healthcare NHS Trust, Imperial College London, London, UK.
Bedi R; Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, London, UK.
Cairns TD; Imperial College Lupus Centre, Imperial College Healthcare NHS Trust, Imperial College London, London, UK.
Lightstone L; Imperial College Lupus Centre, Imperial College Healthcare NHS Trust, Imperial College London, London, UK.

Rheumatology (Oxford) ; 57(7): 1156-1161, 2018 Jul 01.

Article en En | MEDLINE | ID: mdl-29562252

Palabras clave

B cell depletion; anti-CD20; biologic therapy; human-anti-chimeric antibodies; lupus nephritis; monoclonal antibody; ofatumumab; rituximab; systemic lupus erythematosus

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google